PLSE - NASDAQ

Pulse Biosciences, Inc.

PLSE·NASDAQ

$27.64

+11%

HealthcareMedical - Instruments & Supplies

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.91B

EPS-1.0800

P/E Ratio-25.59

Earnings Date08/11/2026

plse

Other Non-Cash Items

Last Annual Value

1.15M

3-Year CAGR

-49%

5-Year CAGR

58%

10-Year CAGR

-4%

Adjust for Inflation

Pulse Biosciences, Inc. Competitors Analysis of Other Non-Cash Items

PLSE · NASDAQ

Company	Other Non-Cash Items	CAGR 3Y	CAGR 5Y	CAGR 10Y
Pulse Biosciences, Inc. NASDAQ:PLSE	1.15M	346.0%	145.2%	2.8%
NovoCure Limited NASDAQ:NVCR	87.67M	N/A	96.3%	88.5%
Nektar Therapeutics NASDAQ:NKTR	-15.58M	N/A	N/A	N/A
Kestra Medical Technologies, Ltd. NASDAQ:KMTS	10.11M	11.6%	39.1%	N/A
OPKO Health, Inc. NASDAQ:OPK	976.00K	-64.6%	N/A	-28.3%
Dianthus Therapeutics, Inc. NASDAQ:DNTH	-6.67M	N/A	N/A	N/A
Beta Bionics, Inc. NASDAQ:BBNX	56.82M	76.9%	N/A	N/A
Atai Beckley Inc. NASDAQ:ATAI	562.84M	N/A	103.7%	N/A
LifeMD, Inc. NASDAQ:LFMD	-10.31M	N/A	N/A	N/A
STAAR Surgical Company NASDAQ:STAA	26.55M	130.0%	65.9%	40.0%

Pulse Biosciences, Inc. Fair Value Envelope

PLSE · NASDAQ

Our analysis suggests that PLSE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $27.6372, this represents a potential HIDDEN relative to our calculated worth for Pulse Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $27.6372

Related Guides

Blog Categories

Continue your PLSE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.